Literature DB >> 8915719

Simultaneous dobutamine stress echocardiography and dobutamine scintigraphy (99mTc-MIBI-SPET) for assessment of coronary artery disease.

V De Bello1, C R Bellina, N Molea, L Talarico, G Boni, E Magagnini, F Matteucci, D Giorgi, E Lazzeri, A Bertini, M F Romano, R Bianchi, C Giusti.   

Abstract

BACKGROUND: Simultaneous dobutamine stress echocardiography (DSE) and 99Tc-MIBI-SPET (DMS) for the evaluation of the presence and the extent of coronary artery disease (CAD) were assessed for a head to head comparison regarding the diagnostic acuracy of the two rests. METHODS AND
RESULTS: Forty-five consecutive patients (33 males and 12 females: 53 +/- 6.8 yr.) underwent exercise electrocardiography and simultaneous dobutamine stress echocardiography and MIBI-SPET imaging. Coronary angiography was performed in all patients (significant coronary stenosis > 50%). On the basis of the results of exercise electrocardiogram the pre-test probability for coronary artery disease (Diamond's algorithm) was low (45.6 +/- 12.7%). The overall specificity, sensitivity and predictive accuracy of Echo-dobutamine stress test for diagnosis of the presence or absence of CAD were: specificity 82%, sensitivity 76%, diagnostic accuracy 80%, positive predictive value 90%, negative predictive value 40%. The overall specificity, sensitivity and predictive accuracy of MIBI-SPET-dobutamine test for diagnosis of the presence or absence of CAD were: specificity 86%, sensitivity 87%, diagnostic accuracy 84%, positive predictive value 97%, negative predictive value 54%. MIBI-SPET-dobutamine test showed a significantly higher sensitivity in comparison with ECHO-dobutamine test (P < 0.05).
CONCLUSION: Both noninvasive methods for the detection of CAD showed a good diagnostic accuracy. Nevertheless the SPET model showed a higher sensitivity in comparison with DSE model, essentially in the presence of a lower extent of CAD and during submaximal test.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8915719     DOI: 10.1007/bf01806221

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  21 in total

1.  The effects of dopamine and dobutamine on regional function in the presence of rigid coronary stenoses and subcritical impairments of reactive hyperemia.

Authors:  M J McGillem; S F DeBoe; H Z Friedman; G B Mancini
Journal:  Am Heart J       Date:  1988-05       Impact factor: 4.749

2.  Dobutamine stress echocardiography: its role in the diagnosis of coronary artery disease.

Authors:  A Salustri; P M Fioretti; M M Pozzoli; A J McNeill; J R Roelandt
Journal:  Eur Heart J       Date:  1992-01       Impact factor: 29.983

Review 3.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

4.  Echocardiographic detection of coronary artery disease during dobutamine infusion.

Authors:  S G Sawada; D S Segar; T Ryan; S E Brown; A M Dohan; R Williams; N S Fineberg; W F Armstrong; H Feigenbaum
Journal:  Circulation       Date:  1991-05       Impact factor: 29.690

5.  Dobutamine stress echocardiography for detection and assessment of coronary artery disease.

Authors:  P K Mazeika; A Nadazdin; C M Oakley
Journal:  J Am Coll Cardiol       Date:  1992-05       Impact factor: 24.094

6.  Dobutamine stress echocardiography: correlation with coronary lesion severity as determined by quantitative angiography.

Authors:  D S Segar; S E Brown; S G Sawada; T Ryan; H Feigenbaum
Journal:  J Am Coll Cardiol       Date:  1992-05       Impact factor: 24.094

7.  Dobutamine digital echocardiography for detecting coronary artery disease.

Authors:  J L Cohen; T O Greene; J Ottenweller; S Z Binenbaum; S D Wilchfort; C S Kim
Journal:  Am J Cardiol       Date:  1991-06-15       Impact factor: 2.778

8.  Thallium scintigraphy during dobutamine infusion: nonexercise-dependent screening test for coronary disease.

Authors:  J R Mason; R T Palac; M L Freeman; S Virupannavar; H S Loeb; E Kaplan; R M Gunnar
Journal:  Am Heart J       Date:  1984-03       Impact factor: 4.749

9.  Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both?

Authors:  T Marwick; A M D'Hondt; T Baudhuin; B Willemart; W Wijns; J M Detry; J Melin
Journal:  J Am Coll Cardiol       Date:  1993-07       Impact factor: 24.094

10.  Exercise echocardiography and technetium-99m MIBI single-photon emission computed tomography in the detection of coronary artery disease.

Authors:  M M Pozzoli; P M Fioretti; A Salustri; A E Reijs; J R Roelandt
Journal:  Am J Cardiol       Date:  1991-02-15       Impact factor: 2.778

View more
  3 in total

1.  A meta-analytic comparison of echocardiographic stressors.

Authors:  Yoshinori Noguchi; Shizuko Nagata-Kobayashi; James E Stahl; John B Wong
Journal:  Int J Cardiovasc Imaging       Date:  2005 Apr-Jun       Impact factor: 2.357

2.  Non-invasive cardiac imaging technologies for the diagnosis of coronary artery disease: a summary of evidence-based analyses.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-06-01

3.  Stress echocardiography for the diagnosis of coronary artery disease: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.